Millennium Management’s Lineage Cell Therapeutics LCTX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$2.36M Buy
+2,600,577
New +$2.36M ﹤0.01% 2569
2024
Q3
Sell
-168,978
Closed -$169K 4286
2024
Q2
$169K Buy
168,978
+127,280
+305% +$127K ﹤0.01% 3614
2024
Q1
$61.7K Sell
41,698
-16,300
-28% -$24.1K ﹤0.01% 3879
2023
Q4
$63.2K Buy
+57,998
New +$63.2K ﹤0.01% 3760
2023
Q2
Sell
-1,402,123
Closed -$2.1M 4507
2023
Q1
$2.1M Buy
1,402,123
+1,003,084
+251% +$1.5M ﹤0.01% 2514
2022
Q4
$467K Sell
399,039
-107,274
-21% -$126K ﹤0.01% 3668
2022
Q3
$572K Sell
506,313
-514,133
-50% -$581K ﹤0.01% 3748
2022
Q2
$1.61M Buy
1,020,446
+841,953
+472% +$1.33M ﹤0.01% 3052
2022
Q1
$275K Sell
178,493
-154,727
-46% -$238K ﹤0.01% 4486
2021
Q4
$816K Buy
333,220
+313,795
+1,615% +$768K ﹤0.01% 3646
2021
Q3
$49K Buy
+19,425
New +$49K ﹤0.01% 4993
2021
Q2
Sell
-1,425,776
Closed -$3.35M 5188
2021
Q1
$3.35M Buy
1,425,776
+1,071,023
+302% +$2.52M ﹤0.01% 2427
2020
Q4
$624K Sell
354,753
-2,775
-0.8% -$4.88K ﹤0.01% 3121
2020
Q3
$335 Buy
357,528
+343,328
+2,418% +$322 ﹤0.01% 3016
2020
Q2
$12K Buy
+14,200
New +$12K ﹤0.01% 3372
2019
Q3
Sell
-54,953
Closed -$60K 3663
2019
Q2
$60K Buy
+54,953
New +$60K ﹤0.01% 3391
2019
Q1
Sell
-18,291
Closed -$17K 3578
2018
Q4
$17K Sell
18,291
-7,649
-29% -$7.11K ﹤0.01% 3285
2018
Q3
$53K Buy
+25,940
New +$53K ﹤0.01% 3414
2018
Q2
Sell
-129,556
Closed -$305K 3586
2018
Q1
$305K Sell
129,556
-42,718
-25% -$101K ﹤0.01% 2976
2017
Q4
$324K Buy
172,274
+155,683
+938% +$293K ﹤0.01% 3080
2017
Q3
$41K Sell
16,591
-61,705
-79% -$152K ﹤0.01% 3161
2017
Q2
$216K Sell
78,296
-129,555
-62% -$357K ﹤0.01% 2927
2017
Q1
$627K Buy
+207,851
New +$627K ﹤0.01% 2461
2015
Q3
Sell
-78,174
Closed -$229K 3361
2015
Q2
$229K Buy
+78,174
New +$229K ﹤0.01% 2794
2014
Q3
Sell
-21,559
Closed -$53K 3024
2014
Q2
$53K Buy
+21,559
New +$53K ﹤0.01% 2734